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Introduction
Cyclooxygenase (COX) converts arachidonic acid to PGH 2 , which is the precursor of distinct PGs. PGs are a group of lipid compounds derived from fatty acids in nearly every cell type (Funk, 2001; Cao et al., 2008) and mediate a variety of important physiologic functions in vivo (McAdam et al., 2000; Burleigh et al., 2002) . For example, PGE 2 promotes tumor initiation, progression and metastasis (Samuelsson et al., 2007) ; while PGD 2 triggers asthmatic responses (Matsuoka et al., 2000) . Both PGE 2 and PGD 2 are converted from PGH 2 by various isoforms of PGE synthase (PGES) and PGDS (Samuelsson et al., 2007; Yu et al., 2011) , respectively. We recently showed that BMDM express all 3 types of PGES including cytosolic PGES (cPGES), microsomal PGES-1 (mPGES-1), and mPGES-2; as well as H-PGDS . H-PGDS is a cytosolic, GSH-dependent enzyme that catalyzes the isomerization of PGH 2 to PGD 2 , whereas L-PGDS is an N-glycosylated, GSH-independent protein (Urade and Eguchi, 2002) .
HQL-79 and AT-56 are reported isoform-selective PGDS inhibitors interdicting H-PGDS-and L-PGDS-mediated PGD 2 production both in vivo and in vitro, respectively (Matsushita et al., 1998a, b; Irikura et al., 2009 ).
ROS are chemical reactive molecules containing oxygen generated during normal and disease-related metabolic processes (Bedard and Krause, 2007; Xiao et al., 2002) , including three major species superoxide (O 2
•-), hydroxyl radical (
• OH), and hydrogen peroxide (H 2 O 2 ). Several major ROS-generating systems in different tissues have been identified, including NOX (Xiao et al, 2002; Cross and Segal, 2004) , mitochondrial electron transport chain (METC) (Balaban et al., 2005) , and nitric oxide synthase (NOS) (Xia et al., 1998) . METC inhibitors, rotenone and antimycin A, have been shown to induce mitochondrial ROS generation from mitochondria
Complex I and Complex III, respectively (Li et al., 2003) . The NOS-selective inhibitor L-NAME This article has not been copyedited and formatted. The final version may differ from this version. prevented NOS-produced NO or ROS generation (Kim et al., 2007) . ROS have been reported to play an important role in carcinogenesis (Benhar et al., 2002) , cardiac myocyte hypertrophy (Amin et al., 2001) , and augmented airway obstruction in asthma (Henricks and Nijkamp, 2001 ).
We have shown that in BMDM, LPS induces both generation of ROS and PGs, which are important mediators in host defense (Park and Christman, 2006; Xiao et al., 2010) . MnTMPyP is a membrane-permeable and non-toxic superoxide dismutase (SOD)/catalase mimetic that efficiently scavenges ROS (i.e. O 2 •-and H 2 O 2 ) both in vivo and in vitro (Amin et al., 2001; Xiao et al., 2002; Zhao et al., 2011) . EUK-134 is another structurally-unrelated and membranepermeable synthetic SOD/catalase mimetic that has been commonly used as a scavenger for intracellular ROS and peroxynitrite (Rong et al., 1999) . Catalase catalyzes the decomposition of H 2 O 2 to water and oxygen (Yu et al., 2006) .
NOX is a membrane-bound multi-subunit enzyme complex (Bedard and Krause, 2007; Lambeth, 2004; Geiszt and Leto, 2004) additional isoforms (Nox1, 3, 4 & 5, and Duox1 & 2) of the NOX catalytic subunit gp91 phox (Nox2) have been reported (Lambeth, 2004; Geiszt and Leto, 2004; Shiose et al., 2000) . The primary enzymatic activity of NOX is to generate superoxide (O 2 •-) by transferring a single zymosan A (zymosan), LPS, rotenone, antimycin A, catalase, H 2 O 2 , Tris base, hydrogen peroxide, citric acid, and EDTA were purchased from Sigma-Aldrich (St. Louis, MO).
MnTMPyP, DPI, PAO, L-NAME, and formic acid were purchased from EMD Chemicals (San Diego, CA). Hydrochloric acid and butylated hydroxytoluene (BHT) were purchased from Thermo Fisher Scientific (Rockford, IL). Purified water was prepared using a Millipore (Billerica, MA) Milli-Q purification system. All organic solvents were HPLC grade or better and were purchased from Thermo Fischer (Rockford, IL), and all other chemicals and solvents were ACS reagent grade, unless stated otherwise.
BMDM isolation and culture. BMDM were isolated from WT C57BL/6 or p47 phox -deficient mice as we previously described (Yu et al., 2011) . Briefly, after mice were euthanized, bone marrow was flushed from the rear femurs. The cells were washed and resuspended in DMEM medium containing 10% endotoxin-free FBS and 10% (v/v) L929 cell-conditioned medium as a biologic source of macrophage colony-stimulating factor. The medium was then replenished at Day 4 in culture, and the non-adherent cells were removed. The adherent bone marrow cells were used for experiments after Day 7 in culture, corresponding to a mature macrophage phenotype.
Western blot assay. Western blot method was similar as we previously described (Cao et al., 2008; Xiao et al., 2002) . Briefly, BMDM were harvested in protein lysis buffer and sonicated for 10 s to shear genomic DNA. Protein concentration was determined by the Bradford assay.
Equal amounts of the denatured proteins in Laemmli sample buffer were subjected to SDS-PAGE, and transferred to a PVDF membrane, blocked with 5% nonfat dry milk, then incubated with primary antibody at 4°C overnight. Protein was detected with horseradish peroxidaseconjugated secondary antibody using SuperSignal enhanced chemiluminescent method.
This article has not been copyedited and formatted. The final version may differ from this version. and the extraction procedure was repeated, then the organic phases were combined and evaporated to dryness. Immediately before analysis using liquid chromatography-tandem mass spectrometry (LC-MS-MS), each extract was reconstituted in methanol/water (50:50, v/v).
Standards for calibration curves and quality control measurements were prepared by spiking 500 μ l aliquots of cell culture medium with measured amounts of PGD 2 and PGE 2 . These standards were then processed as described above. The concentrations of PGD 2 and PGE 2 in these standards ranged from 0.1 to 1000 ng/ml. siRNA transfection. Primary BMDM were transfected with either ON-TARGET plus control siRNA (25 nM) or siRNA's for H-PGDS or L-PGDS (25 nM) using the Amaxa Mouse Macrophage Nuclefector Kit. After 48-h-post-transfection, BMDM were stimulated by LPS (1 μ g/ml) for 16 h.
ROS detection by chemiluminescence assay. The isoluminol-enhanced chemiluminescent assay for ROS detection in BMDM was similar to the previous reports (Dahlgren and Karlsson, 1999; Maeda et al., 2010) . Briefly, primary cultured BMDM were seeded into 96-well culture plate (E&K Scientific) at 5 x 10 4 /well in triplicate, and primed with 100 ng/ml LPS for 16 h prior to ROS measurement. The culture medium was then replaced with phenol red-and serum-free DMEM for subsequent ROS measurement. After pre-incubation with 50 M isoluminol, 40 U/ml HRP, and 100 μ M NADPH at 37°C in dark for 5 min, the BMDM This article has not been copyedited and formatted. The final version may differ from this version. (Yu et al., 2011; Cao et al., 2010; Cao et al., 2011) .
Statistical analysis. Samples were run in triplicate (unless stated otherwise), and values were expressed as mean ± SEM. Statistical significance was assessed using either student t test or one-way analysis of variance (ANOVA), and p value < 0.05 were considered significantly different.
Results

LPS and zymosan induced ROS generation in BMDM.
The Gram-negative bacterial endotoxin LPS is known to selectively activate Toll-like receptor 4 (TLR4) in the mammalian immune system and triggers the secretion of inflammatory cytokines and PGs in macrophages (Azim et al., 2007) . As shown in Figure 1A , LPS treatment concentration-dependently (0.01, 0.1, 1, 5 µg/ml, 16 h) stimulated both PGD 2 and PGE 2 production in BMDM. Since 1 and 5 µg/ml LPS treatment showed similar plateau levels of PGs production, we thus used 1 µg/ml LPS treatment in the following studies. Similarly, LPS treatment also concentration-dependently (0.01, 0.1, 1 µg/ml) induced ROS generation in BMDM (Fig. 1B) .
Although LPS is known to stimulate ROS production in neutrophils, the reports of LPSinduced ROS generation in macrophages have been controversial in the literature (Deschacht et al., 2010; Pfeiffer et al., 2007; Maeda et al., 2010; Szefler et al., 1989) . In contrast, zymosan consistently stimulates ROS generation in macrophages (Russwurm et al., 1994; Bramble and Anderson, 1998) , and thus was used as a positive ROS stimulus in our studies. Like zymosan stimulation, LPS significantly induced ROS generation in BMDM to a level similar to that of zymosan ( Fig. 1B and 1C) , which was completely abolished by two structurally-unrelated ROS scavengers MnTMPyP (50 µM, Fig. 1C ) or EUK-134 (5 µM Fig. 2C ), suggesting that the ROS scavenger MnTMPyP (50 µM) and EUK-134 (5 µM) pretreatment could efficiently and completely prevent LPS-stimulated ROS generation in BMDM.
ROS regulated PGD 2 production in BMDM. We have previously reported that LPS induced both PGD 2 and PGE 2 production in macrophages via TLR4 pathway (Park and Christman, 2006; Xiao et al, 2010) . In the current studies, we found that pretreatment of BMDM with the ROS scavenger MnTMPyP not only concentration-dependently attenuated the LPSThis article has not been copyedited and formatted. The final version may differ from this version. stimulated ROS generation ( Fig. 2A ), but also significantly and selectively decreased LPSinduced PGD 2 production by about 85% at 50 µM (Fig. 2B) ; whereas the LPS-induced PGE 2 production was not affected (Fig. 2B) . Similarly, pretreatment of BMDM with another structurally-unrelated ROS scavenger EUK-134 also concentration-dependently (0.5, 2, 5 µM) attenuated the LPS-stimulated ROS generation ( Fig. 2C ) and production of PGD 2 , but not PGE 2 (Fig. 2D) . Conversely, when increasing the overall cellular ROS level by directly adding H 2 O 2 (0.3 mM) in BMDM, the LPS-induced production of PGD 2 , but not PGE 2 , was selectively and significantly enhanced by over 65%. In contrast, H 2 O 2 treatment alone could not induce any detectable PGs production in BMDM (Fig. 2E ). When BMDM were pretreated with a COX-2-selective inhibitor NS-398 (0.5 h), LPS-induced both PGE 2 and PGD 2 production were concentration-dependently (0.001 to 0.1 μM), but non-selectively inhibited to the same extent at each tested concentration (Fig. 2F ). This result is completely different from our above observation using ROS scavengers or H 2 O 2 (only production of PGD 2 , but not PGE 2 , was affected), suggesting that the observed ROS effect on PG production is not likely acting on the COX-2 enzyme. induced PGD 2 production by around 80% (Fig. 3B ). Since DPI may also inhibit other potential ROS generating enzymes containing flavin-protein (i.e., NOS or mitochondrial enzymes), we thus next tested the effects of selective inhibitors for NOS or mitochondria on LPS-induced PGD 2 production. In contrast, pretreatment of BMDM with mitochondrial inhibitor rotenone (1 µM) and antimycin A (1 µM), or the NOS inhibitor L-NAME (1 mM) had no effect on LPSinduced production of either PGD 2 or PGE 2 (Fig. 3C) , thus excluding the possibility of mitochondria and NOS as the potential ROS generators in BMDM regulating LPS-stimulated PGD 2 production. Taken together, these data suggested that NOX, but not mitochondria or NOS, was the potential ROS generator in response to the LPS treatment in mouse BMDM.
NOX regulated PGD
In order to confirm our above finding using pharmacological inhibitors, we next used molecular approach to test our hypothesis in our studies. NOX is a multi-subunit enzyme that requires the presence of a critical cytosolic subunit p47 phox for its enzyme activity of ROS generation. The p47 phox -deficient transgenic mice showed significantly attenuated ability of NOX-mediated ROS production in neutrophils (Bäumer et al., 2008; Leto et al., 2009 ). Similar to the above inhibitory effects observed with MnTMPyP, EUK-134, DPI and PAO, the LPSinduced production of PGD 2 , but not PGE 2 , was significantly lowered by about 60% in BMDM from the p47 phox -deficient mice compared to that from the WT mice; whereas DPI and PAO showed no further inhibitory effect on LPS-induced PGD 2 production in p47 phox -deficient BMDM (Fig. 3D ). This result from the p47 phox -deficient transgenic mouse confirmed that NOX/p47 phox was involved in regulating LPS-induced PGD 2 production.
Both DPI and PAO inhibited the LPS-induced ROS generation in WT BMDM (Fig. 3E (Fig. 3E) . Similarly, the LPS-induced production of PGD 2 , but not PGE 2 , was attenuated by about 60% in p47 phox -deficient BMDM (Fig. 3D ). 4B) had no effect on either H-PGDS or LPS-induced COX-2 expression, suggesting that the inhibitory effect of MnTMPyP, DPI and PAO on PGD 2 production was not via the inhibition of COX-2 or H-PGDS enzyme expression. In addition, using two different isoform-selective antibodies targeting for mouse L-PGDS isomerase with the mouse brain tissue as a positive control, our Western blot results indicated no detectable L-PGDS protein expression in mouse BMDM (Fig. 4C ), suggesting that L-PGDS was not likely to be the PGDS isoform that mediated LPS-induced PGD 2 production. To further identify the PGDS isomerases involved in this signaling pathway, siRNA's for both H-PGDS and L-PGDS, H-PGDS-selective inhibitor HQL-79, and L-PGDS-selective inhibitor AT-56 were used. Selective inhibition of H-PGDS protein expression using its siRNA (Fig. 4D ) significantly attenuated LPS-induced PGD 2 production by about 55% in BMDM (Fig. 4E) ; whereas siRNA for L-PGDS did not show any inhibitory effect on LPS-induced PGD 2 production (Fig. 4E) . Additionally, the H-PGDS-selective inhibitor HQL-79 concentration-dependently (5, 20, 100 µM) attenuated LPS-induced PGD 2 production in BMDM (Fig. 5A) ; whereas the L-PGDS-selective inhibitor AT-56 (5, 20, 100 µM) had no such This article has not been copyedited and formatted. The final version may differ from this version. Co-incubation of recombinant enzyme H-PGDS and its substrate PGH 2 with either MnTMPyP (10, 50, 500 µM, Fig. 6A ), EUK-134 (2, 5, 20 µM, Fig. 6B ), or catalase (10, 100, 1000 units, Fig. 6D ) showed concentration-dependent attenuation of H-PGDS-mediated PGD 2 production; whereas co-incubation with H 2 O 2 (1, 5, 10 µM) significantly promoted H-PGDS-mediated PGD 2 production (Fig. 6E) . In contrast, co-incubation of recombinant enzyme mPGES-1 and its substrate PGH 2 with MnTMPyP, EUK-134, catalase, or H 2 O 2 showed no significant effect on PGE 2 production under the same experimental conditions in vitro (Fig. 6F) . Since there is no other cytosolic factors or enzymes present in this simple cell-free reaction system except for the recombinant isomerase (i.e., either H-PGDS or mPGES-1) and its substrate PGH 2 in PBS buffer, these in vitro cell-free enzyme assay results confirmed that the ROS level or redox state surrounding the H-PGDS enzyme directly affect its enzymatic capability of PGD 2 production.
H-PGDS mediates LPS-induced PGD
Unlike mPGES-1, an adequate basal level of ROS is required for H-PGDS activity of PGD 2 production in vitro. To strengthen our conclusion, we further determined the basal oxidant level in the above enzyme reaction mixture, which showed significant decrease of ROS signals (i.e.,
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Discussion
In our studies, we showed that inhibition of LPS-stimulated ROS production in BMDM also selectively inhibited the production of PGD 2 , but not its isomer PGE 2 . LPS-induced PGD 2 production in BMDM was mediated via H-PGDS isomerase, but not L-PGDS. LPS-induced H-PGDS-mediated PGD 2 production was sensitive to and dependent on the NOX-generated ROS in BMDM. In contrast, the LPS-induced PGE 2 production in BMDM was ROS-independent.
To our knowledge, this is the first report of the role of ROS in differential regulation of LPS-induced PGD 2 and PGE 2 production. The novel finding of our study is that the modulation of intracellular ROS levels in macrophages could selectively regulate LPS-induced production of PGD 2 , but not PGE 2 . Therefore, it is impossible that the ROS or any NOX/ROS inhibitors exert their selective effects on PGD 2 production via the modification of COX-2 enzyme in BMDM.
Because if there is any modifications of the COX-2 protein expression or its enzyme activity by the above inhibitors or H 2 O 2 , the production of both PGE 2 and PGD 2 would accordingly change uniformly in the same direction as shown in Fig. 2F with the COX-2 selective inhibitor NS-398, but not unilaterally with only one product PGD 2 , as COX-2 is the common upstream ratelimiting PGs synthase for both PGE 2 and PGD 2 . Thus this ROS effect must occur further downstream from the COX-2 enzyme and is only specific for the PGD 2 signaling pathway.
Although previous reports have not shown a consensus on whether ROS could regulate COX-2 expression in different cell types (Feng et al., 1995) , in our hands, LPS-induced ROS production clearly had no inhibitory effect on either COX-2 protein expression or its enzyme activity in BMDM as shown by the unaffected downstream product PGE 2 generation.
Previous reports indicated that ROS generated from NOX played important roles in regulating the expression of several pro-inflammatory genes in macrophages (Hsu and Wen, This article has not been copyedited and formatted. The final version may differ from this version. In order to understand the ROS-dependent signaling mechanism of PGD 2 generation, we first identified the PGDS isoform(s) that mediated LPS-induced PGD 2 production. Between the two cloned PGDS isoforms, L-PGDS was not detected in mouse BMDM with or without LPS stimulation, and inhibition of L-PGDS by either AT-56 or its siRNA failed to prevent LPSinduced PGD 2 production in BMDM. Therefore, the potential role of L-PGDS in LPS-induced PGD 2 production in BMDM is eliminated. In contrast, we found strong H-PGDS expression in BMDM, and H-PGDS-selective inhibitor HQL-79 or its siRNA significantly attenuated LPSinduced PGD 2 production. In addition, co-pretreatment of BMDM with HQL-79 and either DPI or PAO showed additive inhibitory effects on LPS-induced PGD 2 production, suggesting that NOX-regulated LPS-induced PGD 2 production via H-PGDS isoform. Taken together, these data confirmed that H-PGDS mediated LPS-induced PGD 2 production in BMDM.
In order to determine the mechanism of ROS regulation on H-PGDS, an in vitro cell-free enzyme assay was conducted. Scavenging ROS in the H-PGDS reaction system by either SOD/catalase mimetics MnTMPyP and EUK-134, or catalase concentration-dependently attenuated H-PGDS-mediated PGD 2 production, which was significantly enhanced by the addition of H 2 O 2 . In contrast, these reagents have not inhibitory effect on PGE 2 production mediated by mPGES-1. These results indicated that the ROS levels could directly affect the in vitro enzyme activity of H-PGDS, but not mPGES-1, and a certain amount of ROS is required to maintain H-PGDS enzyme activity. We showed that MnTMPyP or EUK-134 could further decrease the ROS level in the enzyme reaction mixture, confirming the presence of a basal level of oxidants (i.e. superoxide) in this enzyme reaction solution. These enzyme assay data strongly This article has not been copyedited and formatted. The final version may differ from this version. Although our enzyme assay results confirmed that ROS could directly modify H-PGDS enzyme activity in vitro, the precise and complete molecular mechanism of ROS regulation on H-PGDS-mediated PGD 2 production in macrophages is still not entirely defined. Our data didn't completely exclude the possibility that ROS may also work through other intracellular signaling intermediates (e.g., kinases) to modify H-PGDS enzyme activity in macrophages in addition to the above confirmed mechanism of direct ROS interaction with H-PGDS. The potential mechanisms of ROS regulate H-PGDS-, but not L-PGDS-, mediated PGD 2 production in BMDM may result from the differences between H-PGDS and L-PGDS as follows: 1) The enzyme activity of H-PGDS is glutathione (GSH)-dependent, whereas L-PGDS enzyme activity doesn't require GSH (Urade and Eguchi, 2002) . GSH is a well-known antioxidant protein with its thiol groups acting as reducing agents, preventing damage to important cellular enzymes or components caused by ROS. GSH reduces disulfide bonds formed within cytoplasmic proteins to cysteines, and is thus converted to its oxidized form glutathione disulfide (GSSG), which can be reduced back by glutathione reductase, using NADPH as an electron donor. It is possible that the NOX inhibitors or ROS scavengers changed the cytosolic ratio of GSH/GSSG, and thus affected the enzyme activity of H-PGDS. 2) H-PGDS and L-PGDS may have different sensitivities to redox environment. Since the L-PGDS is not detectable in our system, thus the different sensitivities of the two isomerases to redox environment are not likely to be the main mechanism of ROS regulated PGD 2 production in BMDM. 3) ROS may facilitate the formation of a hydrogen bond that is a required for H-PGDS activation (Uchida et al., 2010) .
Our in vitro enzyme assay results strongly suggested the critical role of ROS-(H-PGDS) interaction in
This article has not been copyedited and formatted. The final version may differ from this version. modulation of H-PGDS activity, suggesting ROS may serve as an indispensable co-factor for maintaining the normal enzyme configuration and activity of H-PGDS; whereas depletion of ROS would decrease or abolish its enzyme activity.
In our studies, MnTMPyP (50 µM) inhibited PGD 2 production more efficiently in BMDM (~85% inhibition) compared to that from the cell-free enzyme assay (~60% inhibition).
This could be explained by the non-enzymatic conversion of PGH 2 in aqueous solution. We recently reported the spontaneous conversion of PGH 2 to PGE 2 (42.7%) and PGD 2 (24.2%)
without the presence of PGES or PGDS enzymes in the cell-free enzyme assay (Yu et al., 2011) .
These findings suggested that unlike in macrophages, a large portion of PGD 2 was spontaneously converted from PGH 2 independent of H-PGDS enzyme activity in this cell-free enzyme assay, and thus would not be affected by the changes of its surrounding ROS levels (i.e., MnTMPyP concentrations). Currently, it is still unclear if the spontaneous conversion of PGH 2 to PGD 2 in vitro also occurs in live cells (i.e., BMDM). However, this observation could explain why MnTMPyP reduced the PGD 2 production by 60% in the cell-free enzyme assay, but more efficiently blocked PGD 2 production in BMDM.
In conclusion, our results, for the first time, showed that LPS-induced PGD 2 production in BMDM was mediated by H-PGDS that required NOX-derived ROS to maintain its proper enzymatic function. ROS could directly modulate the H-PGDS enzyme activity of PGD 2 production in vitro, but not the mPGES-1 enzyme activity of PGE 2 production. Our findings not only illustrate the critical role of intracellular ROS in differential regulation of PGs production in macrophages, but also implicate a potential new therapeutic strategy in selectively regulating PGD 2 production in the treatment of PGs-involved diseases by regulating the intracellular ROS levels.
This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. Primary cultured WT BMDM were stimulated with 1 μ g/ml LPS for detection the production of
PGs (16 h) and ROS using LC-MS-MS or chemiluminescence assay, respectively. The pretreatment of BMDM with the ROS scavenger MnTMPyP not only concentration-dependently
(1, 5, and 50 µM, 0.5 h) prevented the LPS-induced ROS generation (n=8) (A), but also the LPSinduced (n=9) production of PGD 2 , but not PGE 2 (B). Similarly, another structurally-unrelated ROS scavenger EUK-134 also concentration-dependently (0.5, 2, and 5 µM, 0.5 h, n=3)
prevented LPS-induced ROS generation (C) and the production of PGD 2 , but not PGE 2 , in This article has not been copyedited and formatted. The final version may differ from this version. were selectively attenuated by H-PGDS siRNA (n=3), but not by L-PGDS siRNA (n=2); whereas siRNA for either H-or L-PGDS had no effect on LPS-induced PGE 2 production.
Densitometric quantification of the relative protein expression of COX-2, H-PGDS, or L-PGDS (all normalized to its actin expression) determined by Western blots were also shown in A-D. Figure 6
